Novel molecular targets for prostate cancer therapy

J. M. Kamradt, K. J. Pienta

Research output: Contribution to journalReview articlepeer-review

Abstract

The treatment options available for advanced prostate cancer are increasing. These improved therapies are the result of research involving cellular targets other than DNA proliferation. For example, therapy directed against the intracellular matrix has yielded clinical responses in patients. Other novel targets are being investigated. This review examines both laboratory and clinical advances using cell structure, growth factors, differentiating agents, angiogenesis, metastasis, and the cell cycle in the treatment of prostate cancer.

Original languageEnglish (US)
Pages (from-to)234-243
Number of pages10
JournalSeminars in oncology
Volume26
Issue number2
StatePublished - May 18 1999
Externally publishedYes

ASJC Scopus subject areas

  • Hematology
  • Oncology

Fingerprint Dive into the research topics of 'Novel molecular targets for prostate cancer therapy'. Together they form a unique fingerprint.

Cite this